Sam L Barker - Net Worth and Insider Trading
Sam L Barker Net Worth
The estimated net worth of Sam L Barker is at least $80,728 dollars as of 2024-04-26. Sam L Barker is the Director of Lexicon Pharmaceuticals Inc and owns about 52,187 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $80,368. Sam L Barker is also the Director of Cyclacel Pharmaceuticals Inc and owns about 225 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $360. Details can be seen in Sam L Barker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sam L Barker has not made any transactions after 2021-11-30 and currently still holds the listed stock(s).
Transaction Summary of Sam L Barker
Sam L Barker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sam L Barker owns 2 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) , and Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of Sam L Barker’s form 4 insider trades.
Insider Ownership Summary of Sam L Barker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2021-11-30 | director |
| LXRX | Lexicon Pharmaceuticals Inc | 2019-08-02 | director |
Sam L Barker Latest Holdings Summary
Sam L Barker currently owns a total of 2 stocks. Among these stocks, Sam L Barker owns 52,187 shares of Lexicon Pharmaceuticals Inc (LXRX) as of August 2, 2019, with a value of $80,368 and a weighting of 99.55%. Sam L Barker also owns 225 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of November 30, 2021, with a value of $360 and a weighting of 0.45%.
Latest Holdings of Sam L Barker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2019-08-02 | 52,187 | 1.54 | 80,368 |
| CYCC | Cyclacel Pharmaceuticals Inc | 2021-11-30 | 225 | 1.60 | 360 |
Holding Weightings of Sam L Barker
Sam L Barker Form 4 Trading Tracker
According to the SEC Form 4 filings, Sam L Barker has made a total of 1 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 24,000 shares on August 2, 2019, which cost Sam L Barker around $28,320.
According to the SEC Form 4 filings, Sam L Barker has made a total of 2 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Cyclacel Pharmaceuticals Inc is the sale of 1 shares on November 30, 2021, which brought Sam L Barker around $43.
Insider Trading History of Sam L Barker
- 1
Sam L Barker Trading Performance
GuruFocus tracks the stock performance after each of Sam L Barker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sam L Barker is 44%. GuruFocus also compares Sam L Barker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sam L Barker within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sam L Barker's insider trading performs compared to the benchmark.
Performance of Sam L Barker
Average Return
-9.78%
Outperforming Transactions
40%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.62 | 44 | 10.12 | -9.78 | -15.2 | -3.33 |
| Relative Return to S&P 500(%) | 0.9 | 42.6 | 11.37 | -7.95 | -21.16 | -10.81 |
Sam L Barker Ownership Network
Ownership Network List of Sam L Barker
Ownership Network Relation of Sam L Barker
Sam L Barker Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Sam L Barker is the director of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Sam L Barker made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
Sam L Barker Mailing Address
Above is the net worth, insider trading, and ownership report for Sam L Barker. You might contact Sam L Barker via mailing address: 51 Aunt Molly Road, Hopewell Nj 08525.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
